Literature DB >> 9117167

Biochemical evidence for altered subchondral bone collagen metabolism in osteoarthritis of the hip.

J P Mansell1, J F Tarlton, A J Bailey.   

Abstract

Osteoarthritis (OA) of the hip is invariably viewed as a disease primarily affecting the articular cartilage. Data presented in this report, however, demonstrate changes in the metabolic activity of the underlying trabecular bone tissue, the processes of which may represent a significant factor in the pathogenesis of hip OA. Trabecular bone tissue from OA subjects expressed significantly more matrix metalloproteinase (MMP)-2 (gelatinase A, 72 kDa type IV collagenase) when compared to age-matched osteoporotic (OP) and normal bone tissue. Alkaline phosphatase was also significantly elevated in OA bone tissue. The combination of increased MMP-2 and alkaline phosphatase indicates heightened collagen turnover in the subchondral bone compartment of osteoarthritic hips. The data obtained from this study warrant a closer investigation into the significance of these changes in OA and emphasize the multifactorial elements of the whole joint in the whole joint in the overall disease process.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9117167     DOI: 10.1093/rheumatology/36.1.16

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  36 in total

1.  Interleukin-6 from subchondral bone mesenchymal stem cells contributes to the pathological phenotypes of experimental osteoarthritis.

Authors:  Xiaofeng Wu; Lei Cao; Fan Li; Chao Ma; Guangwang Liu; Qiugen Wang
Journal:  Am J Transl Res       Date:  2018-04-15       Impact factor: 4.060

Review 2.  Targeting subchondral bone for treating osteoarthritis: what is the evidence?

Authors:  Steeve Kwan Tat; Daniel Lajeunesse; Jean-Pierre Pelletier; Johanne Martel-Pelletier
Journal:  Best Pract Res Clin Rheumatol       Date:  2010-02       Impact factor: 4.098

Review 3.  Bone remodelling in osteoarthritis.

Authors:  David B Burr; Maxime A Gallant
Journal:  Nat Rev Rheumatol       Date:  2012-08-07       Impact factor: 20.543

4.  Comparison of loading rate-dependent injury modes in a murine model of post-traumatic osteoarthritis.

Authors:  Kevin A Lockwood; Bryce T Chu; Matthew J Anderson; Dominik R Haudenschild; Blaine A Christiansen
Journal:  J Orthop Res       Date:  2013-09-09       Impact factor: 3.494

Review 5.  Bone Microdamage in Acute Knee Injury.

Authors:  Logeswaran Selvarajah; Annie M Curtis; Oran D Kennedy
Journal:  Curr Rheumatol Rep       Date:  2018-11-21       Impact factor: 4.592

6.  Trabecular structural changes in the mandibular condyle caused by degenerative osteoarthritis: a comparative study by cone-beam computed tomography imaging.

Authors:  Saadettin Kayipmaz; Saliha Akçay; Ömer Said Sezgin; Celal Çandirli
Journal:  Oral Radiol       Date:  2018-03-26       Impact factor: 1.852

7.  Evaluation of a dynamic bayesian belief network to predict osteoarthritic knee pain using data from the osteoarthritis initiative.

Authors:  Emily W Watt; Emily Watt; Alex A T Bui; Alex At Bui
Journal:  AMIA Annu Symp Proc       Date:  2008-11-06

8.  Modulation of OPG, RANK and RANKL by human chondrocytes and their implication during osteoarthritis.

Authors:  Steeve Kwan Tat; Nathalie Amiable; Jean-Pierre Pelletier; Christelle Boileau; Daniel Lajeunesse; Nicolas Duval; Johanne Martel-Pelletier
Journal:  Rheumatology (Oxford)       Date:  2009-09-17       Impact factor: 7.580

9.  Treatment with licofelone prevents abnormal subchondral bone cell metabolism in experimental dog osteoarthritis.

Authors:  D Lajeunesse; J Martel-Pelletier; J C Fernandes; S Laufer; J-P Pelletier
Journal:  Ann Rheum Dis       Date:  2004-01       Impact factor: 19.103

10.  Altered mineralization of human osteoarthritic osteoblasts is attributable to abnormal type I collagen production.

Authors:  Denis Couchourel; Isabelle Aubry; Aline Delalandre; Martin Lavigne; Johanne Martel-Pelletier; Jean-Pierre Pelletier; Daniel Lajeunesse
Journal:  Arthritis Rheum       Date:  2009-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.